Click on a faculty member's name to learn more about their research.
| Department and Faculty | Area of Study | |
|---|---|---|
| Behavioral Science | ||
| Dr. Joshua Lile | human laboratory models of substance use disorders | |
| Dr. Craig Rush | behavioral and pharmacological interventions for the management of stimulant dependence. | |
| Dr. William Stoops | novel treatments of alcohol and stimulant use disorders | |
| Dr. Michael Wesley | neuroimaging, noninvasive brain stimulation, clinical pharmacology | |
| Biology | ||
| Dr. Vincent Cassone | chronobiology | |
| Dr. Robin Cooper | invertebrate models of neurophysiology | |
| Dr. Elizabeth Debski | retinal development | |
| Dr. Bruce O'Hara | circadian rhythms/genetics | |
| Dr. Julie Pendergast | circadian rhythms | |
| Dr. Jessica Santollo | neuroendocrinology, sex differences, homeostasis, ingestive behaviors | |
| Chemistry | ||
| Dr. D. Allan Butterfield | free radical chemistry/Alzheimer's disease | |
| Dr. Mark Lovell | biochemistry of Alzheimer's disease | |
| Dr. Chris Richards | nanotechnology in neuroscience, nicotine | |
| Entomology | ||
| Dr. Clare Rittschof | Behavioral plasticity of insects | |
| Molecular and Cellular Biochemistry | ||
| Dr. Emelia Galperin | biochemistry of congenital disorder | |
| Dr. Louis Hersh | biochemistry of neurodegenerative diseases | |
| Dr. M. Paul Murphy | biochemistry of neurodegenerative diseases | |
| Dr. David Rodgers | enzymology of neurodegenerative diseases, neuromuscular disorders and pain relief | |
| Dr. Maj-Linda B. Selenica | molecular pathways and therapeutic approaches in Alzheimer's disease | |
| Neurology | ||
| Dr. Ed Kasarkis | neuromuscular disease | |
| Dr. Greg Jicha | Alzheimer's and related diseases | |
| Dr. Keith Pennypacker | stroke and neurovascular disorders | |
| Dr. Sharoon Qaiser | headache | |
| Dr. Tritia Yamasaki | movement disorders | |
| Neuroscience | ||
| Dr. Warren Alilain | spinal cord injury and respiratory dysfunction | |
| Dr. Adam Bachstetter | traumatic brain injury, neuroinflammation | |
| Dr. Guoying Bing | Parkinson's disease | |
| Dr. Luke Bradley | biotherapeutics in neuroscience | |
| Dr. Wayne Cass | stimulant abuse | |
| Dr. Salvatore Cherra | synaptic transmission and c. elegans | |
| Dr. Meifan Amy Chen | reactive astrocyte, functions, regulation, and diversity | |
| Dr. Marilyn Duncan | age-related changes in circadian rhythms | |
| Dr. Greg Gerhardt | Parkinson's disease | |
| Dr. Brian Gold | aging and Alzheimer's disease | |
| Dr. Richard Grondin | Parkinson's and Huntington's diseases | |
| Dr. Daniel Lee | inflammation, arginine metabolism, amino acid sensing and tauopathies | |
| Dr. Josh Morganti | neurodegeneration, traumatic brain injury | |
| Dr. Pavel I. Ortinski | neurophysiology of drug use | |
| Dr. Ann Stowe | understanding how the immune system shapes neuroplasticity after brain injury | |
| Dr. Patrick Sullivan | CNS injury/mitochondria | |
| Dr. Linda Van Eldik | Alzheimer's disease | |
| Dr. S. Randal Voss | axolotl, tissue regeneration, spinal cord, genetics, genomics, epigenetic | |
| Dr. Tritia Yamasaki | Parkinson's, synucleinopathies | |
| Dr. Zhiming Zhang | neuroimaging/Parkinson's disease | |
| Neurosurgery | ||
| Dr. Justin Fraser | cerebrovascular disease, ischemic stroke | |
| Dr. Jill Roberts | CNS disease of vascular pathology | |
| Dr. Amanda Trout | biomarkers of neurovascular changes after cerebrovascular injury | |
| Pharmaceutical Sciences | ||
| Dr. Björn Bauer | blood-brain-barrier/epilepsy | |
| Dr. Linda Dwoskin | nicotine receptors and dependence | |
| Dr. Anel Jaramillo | neurocircuits modulating alcohol abuse, stress, and anxiety | |
| Dr.Jonghyuck Park | immunoengineering, spinal cord injury, gene therapy, and nanomedicine | |
| Dr. Jill Turner | nicotine addiction | |
| Pharmacology and Nutritional Sciences | ||
| Dr. Eric Blalock | stress/sleep/aging | |
| Dr. Gang Chen | alcohol neurotoxicity | |
| Dr. Kuey Chu Chen | genetics/aging/stress | |
| Dr. Cassandra Gipson-Reichardt | neurobiological and behavioral mechanism of addiction | |
| Dr. Richard Grondin | Parkinson's and Huntington's Disease Treatment | |
| Dr. Anika Hartz | blood-brain barrier/Alzheimer's disease | |
| Dr. Philip Landfield | brain aging | |
| Dr. Chris Norris | brain aging, calcium regulation | |
| Dr. Nada Porter | brain aging, calcium regulation | |
| Dr. Olivier Thibault | brain aging, calcium regulation | |
| Physiology | ||
| Dr. Brian Delisle | epilepsy and cardiac function | |
| Dr. Steve Estus | genetics/Alzheimer's disease | |
| Dr. Gregory Frolenkov | cellular function and hearing | |
| Dr. John Gensel | traumatic brain injury | |
| Dr. W. Brad Hubbard | pathobiology of traumatic brain injury (TBI) | |
| Dr. Lance Johnson | brain metabolism aging, Alzheimer's Disease | |
| Dr. Tim McClintock | genomics and olfaction | |
| Dr. Alexander Rabchevsky | treatment of spinal cord injury | |
| Dr. Kathy Saatman | treatment of traumatic brain injury | |
| Dr. Melinda Wilson | estrogen and brain function | |
| Dr. A. Catalina Velez-Ortega | inner ear sensory organs | |
| Psychology | ||
| Dr. Tom Adams | Improving the understanding of and treatments for anxiety and related disorders | |
| Dr. Josh Beckmann | drug abuse/learning | |
| Dr. Mike Bardo | drug abuse/conditioning | |
| Dr. Mark Fillmore | abused substances and cognitive function in human subjects | |
| Dr. Justin Kerr | Brain Injury, Concussion, Clinical Neuropsychology, Dementia, Cognitive Aging, Executive Functions | |
| Dr. Mark Prendergast | alcohol abuse/neurodegeneration | |
| Dr. Lauren Whitehurst | brain and body interactions during sleep and effects on cognition and health | |
| Dr. Anthony Zanesco | attention, mind wandering, mindfulness, and EEG brain dynamics |
Other mentors not found on this list may supervise independent research activities for BIO 394/ANA394/PSY393 with the approval of the Director of Undergraduate Studies, Dr. Lynda Sharrett. The student must provide Dr. Sharrett with a one-page description of the proposed research activities.
- Independent research activities supervised by mentors not on this list may be eligible for BIO 394/ANA394/PSY393 (Research in Neuroscience) credit if they provide a significant neuroscience experience. To enable this determination, please write a summary of the proposed research activities (no more than one page) that clearly describes the neuroscience aspects of the project, the hypothesis to be tested, the methods used and your role in the project. Submit this summary to the Director of Undergraduate Studies, Dr Lynda Sharrett.